229 related articles for article (PubMed ID: 23314175)
21. A novel mode of action of the putative sphingosine kinase inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl) thiazole (SKI II): induction of lysosomal sphingosine kinase 1 degradation.
Ren S; Xin C; Pfeilschifter J; Huwiler A
Cell Physiol Biochem; 2010; 26(1):97-104. PubMed ID: 20502009
[TBL] [Abstract][Full Text] [Related]
22. Role of sphingosine 1-phosphate receptors, sphingosine kinases and sphingosine in cancer and inflammation.
Pyne NJ; McNaughton M; Boomkamp S; MacRitchie N; Evangelisti C; Martelli AM; Jiang HR; Ubhi S; Pyne S
Adv Biol Regul; 2016 Jan; 60():151-159. PubMed ID: 26429117
[TBL] [Abstract][Full Text] [Related]
23. Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids.
Yan G; Chen S; You B; Sun J
Cardiovasc Res; 2008 May; 78(2):308-14. PubMed ID: 18192241
[TBL] [Abstract][Full Text] [Related]
24. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.
Berdyshev EV; Gorshkova IA; Usatyuk P; Zhao Y; Saatian B; Hubbard W; Natarajan V
Cell Signal; 2006 Oct; 18(10):1779-92. PubMed ID: 16529909
[TBL] [Abstract][Full Text] [Related]
25. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-alpha.
Pettus BJ; Bielawski J; Porcelli AM; Reames DL; Johnson KR; Morrow J; Chalfant CE; Obeid LM; Hannun YA
FASEB J; 2003 Aug; 17(11):1411-21. PubMed ID: 12890694
[TBL] [Abstract][Full Text] [Related]
26. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
Huwiler A; Pfeilschifter J
Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
[TBL] [Abstract][Full Text] [Related]
27. Subcellular origin of sphingosine 1-phosphate is essential for its toxic effect in lyase-deficient neurons.
Hagen N; Van Veldhoven PP; Proia RL; Park H; Merrill AH; van Echten-Deckert G
J Biol Chem; 2009 Apr; 284(17):11346-53. PubMed ID: 19251691
[TBL] [Abstract][Full Text] [Related]
28. Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2.
Adams DR; Tawati S; Berretta G; Rivas PL; Baiget J; Jiang Z; Alsfouk A; Mackay SP; Pyne NJ; Pyne S
J Med Chem; 2019 Apr; 62(7):3658-3676. PubMed ID: 30889352
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine kinase 2 prevents the nuclear translocation of sphingosine 1-phosphate receptor-2 and tyrosine 416 phosphorylated c-Src and increases estrogen receptor negative MDA-MB-231 breast cancer cell growth: The role of sphingosine 1-phosphate receptor-4.
Ohotski J; Rosen H; Bittman R; Pyne S; Pyne NJ
Cell Signal; 2014 May; 26(5):1040-7. PubMed ID: 24486401
[TBL] [Abstract][Full Text] [Related]
30. Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1-phosphate.
Siow DL; Anderson CD; Berdyshev EV; Skobeleva A; Pitson SM; Wattenberg BW
J Lipid Res; 2010 Sep; 51(9):2546-59. PubMed ID: 20386061
[TBL] [Abstract][Full Text] [Related]
31. A Rheostat of Ceramide and Sphingosine-1-Phosphate as a Determinant of Oxidative Stress-Mediated Kidney Injury.
Ueda N
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409370
[TBL] [Abstract][Full Text] [Related]
32. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
[TBL] [Abstract][Full Text] [Related]
33. The role of sphingosine kinase 1/sphingosine-1-phosphate pathway in the myogenic tone of posterior cerebral arteries.
Lim M; Choi SK; Cho YE; Yeon SI; Kim EC; Ahn DS; Lee YH
PLoS One; 2012; 7(4):e35177. PubMed ID: 22532844
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine 1-phosphate and cancer.
Pyne NJ; El Buri A; Adams DR; Pyne S
Adv Biol Regul; 2018 May; 68():97-106. PubMed ID: 28942351
[TBL] [Abstract][Full Text] [Related]
35. Drugging sphingosine kinases.
Santos WL; Lynch KR
ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine kinase/sphingosine 1-phosphate signaling in cancer therapeutics and drug resistance.
Selvam SP; Ogretmen B
Handb Exp Pharmacol; 2013; (216):3-27. PubMed ID: 23563649
[TBL] [Abstract][Full Text] [Related]
37. Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances.
Pyne S; Adams DR; Pyne NJ
Prog Lipid Res; 2016 Apr; 62():93-106. PubMed ID: 26970273
[TBL] [Abstract][Full Text] [Related]
38. In vitro and in vivo roles of sphingosine kinase 2 during dengue virus infection.
Al-Shujairi WH; Clarke JN; Davies LT; Pitman MR; Calvert JK; Aloia AL; Pitson SM; Carr JM
J Gen Virol; 2019 Apr; 100(4):629-641. PubMed ID: 30869582
[TBL] [Abstract][Full Text] [Related]
39. Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity.
Leclercq TM; Moretti PA; Vadas MA; Pitson SM
J Biol Chem; 2008 Apr; 283(15):9606-14. PubMed ID: 18263879
[TBL] [Abstract][Full Text] [Related]
40. The regulation of p53, p38 MAPK, JNK and XBP-1s by sphingosine kinases in human embryonic kidney cells.
Alsanafi M; Kelly SL; McNaughton M; Merrill AH; Pyne NJ; Pyne S
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Apr; 1865(4):158631. PubMed ID: 31954175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]